[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Azienda Ospedaliera di Bolzano\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":80},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,51],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100586058","artificial-intelligence-based-timing-infarct-size-and-outcomes-in-acute-coronary-occlusion-myocardial-infarction-100586058",false,"NCT06910436","Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction","Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction Without ST Elevation","ANOMI","Inclusion Criteria:\n\n* Age \\> 18 yrs\n* Working diagnosis of Non- ST Elevation Acute Coronary Syndrome after the assessment by specialist\n\nExclusion Criteria:\n\n* ST-Elevation Myocardial infarction\n* Age \\\u003C 18 yrs\n* Major sustained ventricular arrhythmias\n* Corrupted ECG images\n* Poor digitalisation quality of the ECG","ALL","18 Years",{"count":20,"type":21},1500,"ESTIMATED","12 Months","OBSERVATIONAL","The present study is practice-driven and merely observational and prospective. In clinical routine, patients who suffer from suspected ACS and do not show ST elevation in the ECG, different timing proposals in the guidelines and logistically driven differences lead to considerably variable timings in invasive coronary anatomy assessments. This handling may lead to larger infarct sizes when OMI is overseen. Therefore, the present study aims to observe a) whether an AI model is capable of correctly identify OMI in eligible patients and b) if in these patients troponin peak levels vary depending on the elapsed time between OMI diagnosis and coronary intervention.\n\nAs the model has not been established yet clinically and in the guidelines, it is safe to assume the usual pathway from first medical contact to specialist's attention is undertaken. When a patient presents in an emergency department or places an emergency call, the physicians assess the situation as usal and as stated in the current guidelines1.\n\nIf no STEMI is confirmed, the NSTE-ACS protocol is started. The patients who are ruled out for ACS are excluded from the final analysis (screening). In this case, the AI model is tested on their ECG in order to assess whether there are false positives.\n\nThe patients which are in the ACS \"rule-in\" trail and undergo final coronary angiography will naturally be divided in patients which were classified as OMI and as non-OMI by the AI model. Furthermore, they will present a different \"Time from OMI diagnosis to PCI) and variable troponin peak levels.\n\nBy leveraging this natural variability, a practical distinction and multiple analyses can be done:\n\n1. The feasibility of AI-powered ECG interpretation in the care of patients with suspected ACS and without clear ST-elevation infarction\n2. The accuracy of AI-powered ECG interpretation in detecting OMI compared to the classical STEMI criteria\n3. How infarct size correlates with different ECG readings by AI and (hypothesis generating) if changing the clinical practice could lead to a benefit in patients with suspected OMI.",[26,27],"Coronary Arterial Disease (CAD)","Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)",[29,30,31,32,33,34,35,36,37],"Artificial Intelligence","ECG","AI","NSTE-ACS","ACS","Acute Coronary Syndrome","Reperfusion times","PCI","Percutaneous Coronary Intervention","RECRUITING","2026-05-21",{"date":41,"type":42},"2026-05-26","ACTUAL",{"date":44,"type":42},"2024-04-01",{"date":46,"type":21},"2026-07-31",{"name":48,"class":49},"Azienda Ospedaliera di Bolzano","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":59,"targetDuration":61,"studyType":23,"phases":4,"briefSummary":62,"conditions":63,"keywords":68,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":50},"100543464","syncope-asystole-latency-time-in-tilt-table-test-the-salt-tilt-study-100543464","NCT06356207","Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study","NeuroArrhythmias Area Registry of AIAC (NAARA) Syncope-Asystole Latency Time in Tilt Table Test (SALT-TILT) Study","SALT-TILT","Inclusion Criteria:\n\n* Patients eligible for invasive treatment according to the ESC Guidelines for pacing 2021\n* Written informed consent\n\nExclusion Criteria:\n\n* Other condition which explains syncope cause other than reflex syncope\n* Structural heart disease (valvular, ischaemic, cardiomyopathies)\n* Pregnancy\n* Patient denial to be recorded on video during tilt table test",{"count":60,"type":21},64,"2 Years","Syncope is a common presenting condition. Pacemaker implantation can significantly reduce syncope recurrences in reflex syncope. However, despite careful selection, a substantial proportion of patients treated with pacemakers suffer recurrences of syncope. It is thought that a pronounced vasodepressor component may hinder the efficacy of pacing in patients, preventing adequate cerebral perfusion during the reflex, thus relativizing the anti-bradycardia function of the pacemaker to prevent syncope. It is hypothesised that the time elapsed from the actual loss of consciousness to the asystole recorded on the ECG during Tilt Table Test may be predictive in terms of response to pacemaker therapy, so this parameter becomes the subject of the present study.",[64,65,66,67],"Syncope","Pacemaker","Asystole","Neurally Mediated Syncope",[64,65,69,66,70,71],"Tilt Table Test","SALT","Syncope-Asystole Latency Time","2024-04-10",{"date":74,"type":42},"2024-04-11",{"date":76,"type":42},"2024-03-20",{"date":78,"type":21},"2027-03",{"name":48,"class":49},""]